GENERAC HOLDINGS INC. (GNRC) — Institutional Holders & Catalysts | BiotechEdge

BiotechEdgeBeta

Catalysts Convergence Compare Insiders Runway Squeeze Signals Research

Sign In Start Free Trial

← Back to home

GENERAC HOLDINGS INC.

GNRC

Held by 2 specialist biotech funds

Fund Holdings

B

BiotechEdge

Catalysts Convergence Insiders Cash Runway Research Pricing

Data sourced from SEC EDGAR and ClinicalTrials.gov. Not investment advice.

Feedback Terms Privacy Disclaimer

Driehaus Capital

Eventide Asset ManagementNew

2 quarters

Position Trend

Nov 14, 2025

$17.1M

1 fund

Feb 13, 2026

$12.8M

1 fund

Feb 17, 2026

$0

0 funds

-100% total institutional value over 3 quarters

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalEXITFeb 17, 2026

Shares: 102,258Value: $17.1M

Eventide Asset ManagementNEWFeb 13, 2026

Shares: 93,860Value: $12.8M

Driehaus CapitalNEW

102,258 shares$17.1M

+ 1more — see how much conviction went in

See the Full Story

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

HD1 fund HLI1 fund CPRT1 fund HUBS1 fund IDYA1 fund LITE1 fund IMMX1 fund PI1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: